These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 9691101

  • 1. Reduction in new metastases in breast cancer with adjuvant clodronate treatment.
    Diel IJ, Solomayer EF, Costa SD, Gollan C, Goerner R, Wallwiener D, Kaufmann M, Bastert G.
    N Engl J Med; 1998 Aug 06; 339(6):357-63. PubMed ID: 9691101
    [Abstract] [Full Text] [Related]

  • 2. [The role of adjuvant clodronate therapy for prevention of bone metastasis in breast cancer].
    Horváth Z.
    Magy Onkol; 2002 Aug 06; 46(4):361-4. PubMed ID: 12563361
    [Abstract] [Full Text] [Related]

  • 3. Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients.
    Saarto T, Vehmanen L, Virkkunen P, Blomqvist C.
    Acta Oncol; 2004 Aug 06; 43(7):650-6. PubMed ID: 15545185
    [Abstract] [Full Text] [Related]

  • 4. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M, Beuzeboc P, Mauriac L, Barbet N, Frenay M, Monnier A, Pion JM, Switsers O, Misset JL, Assadourian S, Bessa E.
    Bull Cancer; 2001 Jul 06; 88(7):701-7. PubMed ID: 11495824
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer.
    Leppä S, Saarto T, Vehmanen L, Blomqvist C, Elomaa I.
    Breast Cancer Res Treat; 2005 Mar 06; 90(2):117-25. PubMed ID: 15803358
    [Abstract] [Full Text] [Related]

  • 7. Current and future status of adjuvant therapy for breast cancer.
    Coleman RE.
    Cancer; 2003 Feb 01; 97(3 Suppl):880-6. PubMed ID: 12548590
    [Abstract] [Full Text] [Related]

  • 8. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ, Mancini I.
    Support Care Cancer; 2002 Jul 01; 10(5):399-407. PubMed ID: 12136223
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.
    Saarto T, Vehmanen L, Blomqvist C, Elomaa I.
    J Clin Oncol; 2008 Sep 10; 26(26):4289-95. PubMed ID: 18779616
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oral bisphosphonates as adjuvant therapy for operable breast cancer.
    Powles T, McCroskey E, Paterson A.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6301s-6304s. PubMed ID: 17062718
    [Abstract] [Full Text] [Related]

  • 13. Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer.
    McCloskey E, Paterson A, Kanis J, Tähtelä R, Powles T.
    Eur J Cancer; 2010 Feb 15; 46(3):558-65. PubMed ID: 20031392
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ, Dranitsaris G, Ooi WS, Yogendran G, Sukovic T, Wong BY, Verma S, Pritchard KI, Trudeau M, Cole DE.
    J Clin Oncol; 2006 Oct 20; 24(30):4895-900. PubMed ID: 17001071
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial.
    Saarto T, Blomqvist C, Virkkunen P, Elomaa I.
    J Clin Oncol; 2001 Jan 01; 19(1):10-7. PubMed ID: 11134190
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.